Rat Model Market Sales, Segments, Capacity Outlook, Growth and Analysis

Major Growth Boosting Factors: The Continuous support in the form of investments and grants, and personalized medicine fueling the demand for personalized humanized rat models are some of the factors driving the growth of the rat model market. Expanding with the increase in R&D activities in pharmaceutical industries. These rat model are being used in many applications such as toxicology, oncology, diabetes, neurology, immunology and infectious diseases, and others (rare disease, cardiovascular, metabolic disease, hematopoiesis, and regenerative medicines).

Revenue Growth Opportunities: The overall Rat Model Market is expected to reach USD 588.9 million, at a CAGR of 8.7%

Major Market Developments;

# In August 2016, Charles River Laboratories, Inc. entered into a strategic partnership with The Milner Therapeutics Institute and Consortium (UK). This partnership with the Consortium allows the academic institutions access to Charles River’s early discovery and drug development and services for the early stage drug development processes.

# In September, 2016, Charles River Laboratories International, Inc. acquired Agilux Laboratories (US), a provider of bioanalytical services, drug metabolism and pharmacokinetic services, and pharmacology services. This acquisition is expected to compliment Charles River’s non-clinical portfolio and improve the clients’ early-stage research efforts by enabling them to seamlessly transition their drug candidates through the discovery and safety assessment process.

# In October 2015, Horizon Discovery Group plc expanded its UK based headquarters. The new facility is likely to accommodate 200 employees across manufacturing, services, research, and general and administrative functions.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=76036494

On the basis of type,

The rat model market is segmented into outbred rats, inbred rats, knockout/genetically engineered rats, hybrid/congenic rats, conditioned/surgically modified rats, and immunodeficient rats model. Knockout/genetically engineered rats segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of knockout/genetically engineered rats segment can be attributed to the use of this type of rat model to carry out researches on disease such as oncology, obesity, heart disease, diabetes, arthritis, drug abuse, anxiety, aging, and Parkinson’s.

On the basis of services,

The rat model market is segmented into breeding, cryopreservation, quarantine, rederivation, model in-licensing, genetic testing, and others such as surgical services, line rescue services, and in vivo pharmacology services. The cryopreservation segment is estimated grow at the highest CAGR during the forecast period, as this segment help in obtaining the genetic material of rats even after the reproductive lifespan of these rats is over. This cuts down time and cost needed for reproduction of rats.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=76036494

Applications of Rat Model Market;

DIABETES;

Rats are considered to be excellent experimental models for understanding the complex genetic basis of diseases such as diabetes. Due to the ever-increasing prevalence of diabetes globally; it has become important to study the mechanism of the disease. However, it is quite difficult to carry out research studies in human beings, owing to problems such as genetic heterogeneity and lack of controlled lifestyles. Rat models act as suitable models to study specific genetic mutations and to understand the function of genes on a homogeneous genetic background.

ONCOLOGY;

Rat models recapitulate various aspects of genesis, progression, and clinical course of human cancers. Hence, they act as ideal study models for cancer researchers engaged in a variety of basic, translational, clinical, and epidemiological investigations.

Global Leaders: Charles River Laboratories International, Inc. (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), Biomere (U.S.), Janvier Labs (France), genOway SA (France), and Horizon Discovery Group plc (U.K.) are some of the key players in the rat model market worldwide

COVID-19 Impact on Critical Care Device Market - Segmentation, Major Players & Geographical Analysis

Major Growth Boosting Factors: The Critical Care Device Market is driven primarily by the increasing number of ICU beds owing to the continuously rising COVID-19 cases, increasing demand for ventilators for effective management of critical COVID-19 patients, and ease of regulatory requirements to facilitate the production of critical care devices. In addition, the development of low-cost ventilators and the expected increase in healthcare budgets offer significant growth opportunities for players operating in the critical care devices market. However, disruption of supply chain & logistics due to the rapid spread of coronavirus is likely to challenge the growth of this market.

Revenue Growth Opportunities: The Global COVID-19 Impact on Critical Care Device Market size is expected to reach USD 27.29 billion by 2021 from an estimated value of USD 37.97 billion in 2020. The critical care devices market is expected to witness a growth of 44.1% from 2019 to 2020.

Recent Developments:

• In April 2020, The FDA issued Emergency Use Authorization for B. Braun’s Perfusor Space Syringe Infusion Pump, Infusomat Space Volumetric Infusion Pump, and Outlook ES Pump systems to deliver nebulized meds into a nebulizer to treat COVID-19 patients.
• To help ensure the continuity of supply, BD has placed all BD and Alaris infusion sets on manual inventory allocation until further notice. As a part of the supply continuity plan, the company is also reducing the number of available product SKU’s of Alaris system pump sets.
• In October 2019, B. Braun Medical Inc. (US) collaborated with STANLEY Healthcare (US) to integrate and deploy B. Braun’s Space Infusion Pump Systems along with DoseTrac Infusion Management Software with STANLEY Healthcare’s MobileView software, Aeroscout RTLS MobileView, at Saratoga Hospital, located in New York, US, to provide real-time pump status data.
• In April 2019, Smiths Medical (US) partnered with HCA Capital Division (US) to integrate the Medfusion 4000 system with PharmGuard Software with HCA’s electronic medical records system (EMR), to provide better patient outcomes by reducing medication errors.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=216430576

Based on products;

The critical care devices market is segmented into ventilators & supplies, sleep apnea devices, patient monitors, hyperbaric oxygen therapy devices, infusion pumps, defibrillators, anesthesia machines, blood warmers, and other critical care devices supplies. The ventilators segment is expected to grow at the highest rate during the forecast period. This can be attributed to owing to rapid manufacturing of emergency ventilators, worldwide, and the development of low-cost ventilators.

Based on end-users;

The critical care devices market has been segmented into hospitals, home care settings, ambulatory care settings, and emergency medical services. The hospitals & clinics segment accounted for the largest share of the critical care devices industry in 2019. The large share of this segment is attributed to the strong financial capabilities of hospitals for purchasing high-priced critical care devices, the large patient pool treated at hospitals, and the availability of trained professionals to operate these critical care devices.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=216430576

Geographical Scenario: The critical care devices market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2019, North America accounted for the largest share of the critical care devices industry. The large share of this region can primarily be attributed to the high adoption of specialty infusion pumps, the high number of positive COVID-19 cases & deaths in the US, a strong healthcare system, and the presence of many large hospitals in the region. Moreover, a large number of major global players are based in the US, owing to which the US can easily manufacture these devices.

Global Leaders: The key players in the global critical care devices market are Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), Medtronic plc (Ireland), ResMed (US), Koninklijke Philips (Netherlands), and Fisher & Paykel Healthcare (New Zealand), among others.

COVID-19 impact on Medical Supplies Market - Comprehensive Research Including Top Key Players and Forecast Report

Major Growth Boosting Factors: The market for medical supplies is driven primarily by the growing awareness on environmental & personal hygiene leading to rising demand for disinfectants , expansion of healthcare settings owing to increasing COVID 19 patients, increased requirement of PPE kits & N95 masks globally, rising demand for ventilators, and increasing demand for diagnostic supplies.

In addition, repurposing liquor production lines to manufacture sanitizers offers an opportunity for players in this market. However, delays in non-urgent treatment and surgical procedures and impact on supply chain and logistics due to lockdown is likely to restrain the growth of this market.

Revenue Growth Opportunities: The COVID-19 impact on Medical Supplies Market is expected to reach USD ~100 billion by 2021 from an estimated value of USD ~78 billion in 2019, growing at a CAGR of ~13.4% during the forecast period.

Recent Developments:

• In April 2020, Baxter received USFDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment.
• In Arizona, the US, SanTan Brewing, has repurposed its beer production line to manufacture hand sanitizer. In April 2020, SanTan began producing 400 gallons of medical-grade hand sanitizer for first responders and healthcare professionals.
• In New York (US), in March 2020, Pernod Ricard’s facility in Fort Smith, Ark. produced 1,000 gallons of hand sanitizer; it originally produced Malibu coconut rum and Seagram’s gin.
• In India (Bengaluru), Diageo India, which sells McDowell’s whiskey and Smirnoff vodka, announced that it would produce 300,000 liters of hand sanitizers to help overcome the shortage.

Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=158189339

Based on type,

The medical supplies market is segmented into intubation and ventilation supplies, disinfectant, personal protective equipment, diagnostic supplies, sterilization supplies, infusion and injectable supplies, dialysis supplies, wound care supplies, radiology supplies, and other medical supplies. The disinfectant segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as the increasing demand for hand sanitizers, rising awareness about personal hygiene, increased consumption of disinfectant in healthcare facilities are driving the growth of the disinfectant market globally.

Based on end users,

The medical supplies market is segmented into hospitals, clinics, and other end-users. The hospital segment is expected to grow at the highest CAGR owing to increasing demand for hospital beds and intensive care units in countries with the increasing incidence of COVID-19, increasing demand for specialized staff such as infectious disease experts providers, respiratory therapists, and physicians and nurses who can provide intensive and critical care, increased consumption of personnel protective equipment within the hospital premises; and the increasing support from government and non-government organization to combat with COVID-19 are the major factors driving the demand and uptake of medical supplies in hospitals growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=158189339

Geographical Scenario:

North America accounted for the largest share of the medical supplies market in 2020, followed by Europe. The large share of this region is attributed mainly to a high number of positive COVID-19 cases and deaths in the US, a strong healthcare system, and the presence of many large hospitals. Moreover, a large number of major global players are based in the US, owing to which the US can easily manufacture these devices.

Global Leaders:

The prominent players in the medical supplies market are Medtronic plc (Ireland), Cardinal Health, Inc. (US), Becton, Dickson and Company (US), Johnson & Johnson (US), and B. Braun Melsungen AG (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), STERIS Corporation (US), Getinge Group (Sweden), Advanced Sterilization Products (US), 3M Company (US), Smith & Nephew (U.K.), Mölnlycke Health Care AB (Sweden),  among others.